trandolapril
Selected indexed studies
- Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders. (Drugs, 1998) [PMID:9829159]
- Trandolapril: a clinical profile. (Am J Hypertens, 1995) [PMID:8845087]
- Trandolapril/verapamil combination in hypertensive diabetic patients. (Vasc Health Risk Manag, 2007) [PMID:17583177]
_Worker-drafted node — pending editorial review._
Connections
trandolapril is a side effect of
Sources
- Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders. (1998) pubmed
- Trandolapril: a clinical profile. (1995) pubmed
- Trandolapril/verapamil combination in hypertensive diabetic patients. (2007) pubmed
- Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension. (2005) pubmed
- Update on the use of trandolapril in the management of cardiovascular disorders. (2008) pubmed
- Tarka® (trandolapril/verapamil hydrochloride extended-release) overdose. (2011) pubmed
- Trandolapril: a newer angiotensin-converting enzyme inhibitor. (2003) pubmed
- Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors? (1993) pubmed
- Fixed combination verapamil SR/trandolapril. (1998) pubmed
- Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. (1994) pubmed